Home LiteratureArticle Details
PMID: 16892027 Published · ppublish English Comment News

Targeted cancer therapeutics: the heartbreak of success.

Nature medicine ·Vol. 12 ·No. 8 ·2006-08-00 ·Pages 881-2

Mann DL

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/therapeutic use Antineoplastic Agents/therapeutic use Benzamides Drug Delivery Systems/methods Enzyme Inhibitors/adverse effects,therapeutic use Heart Failure/chemically induced,physiopathology Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy Models, Biological Neoplasms/drug therapy,therapy Piperazines/therapeutic use,toxicity Pyrimidines/therapeutic use,toxicity Ventricular Dysfunction, Left/chemically induced,physiopathology src-Family Kinases/adverse effects,antagonists & inhibitors
Chemicals
Antibodies, Monoclonal Antineoplastic Agents Benzamides Enzyme Inhibitors Piperazines Pyrimidines Imatinib Mesylate src-Family Kinases
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Mann Douglas L
Article Info
Journal
Nature medicine
Abbr.
Nat Med
ISSN
1078-8956
Published
2006-08-00
Pages
881-2
Language
English
Region
United States
NLM ID
9502015
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com